Results 51 to 60 of about 4,340 (169)

Pure red cell aplasia.

The Quarterly journal of medicine, 1979
Complete or near complete remission of acquired pure red cell aplasia, not associated with thymoma, occurred in response to prednisone (six occasions), prednisone and cyclophosphamide (twice), cyclophosphamide alone (once) and splenectomy (once).
M E, Beard, S B, Krantz, S A, Johnson, C J, Bateman, J M, Whitehouse   +4 more
openaire   +3 more sources

A riboflavin transporter deficiency presenting as pure red cell aplasia: a pediatric case report

Frontiers in Pediatrics
IntroductionRiboflavin transporter deficiency (RTD) is a rare genetic disorder that affects riboflavin transport, leading to impaired red blood cell production and resulting in pure red cell aplasia.
Jingying Cheng, Jiafeng Yao, Shasha Zhao, Lingling Fu, Liqiang Zhang, Jin Jiang   +5 more
doaj   +1 more source

Recurrent Severe Anaemia: A Rare Presentation of Parvovirus B19 Infection [PDF]

Journal of Clinical and Diagnostic Research, 2014
Secondary pure red cell aplasia is usually seen in immunocompromised hosts or patients who have chronic haemolytic anaemia, which is caused by blood transfusion related transmission.
Santokh Singh, Gian Chand, Shiv Charan, Sahil Arora, Parampreet Singh   +4 more
doaj   +1 more source

EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL.
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P. Kater, Carsten U. Niemann, Sarka Pospisilova, Tadeusz Robak, Anna Schuh, Kostas Stamatopoulos, Tamar Tadmor, Nick York   +13 more
wiley   +1 more source

Clinico-Hematological Features in Pure Red Cell Aplasia Patients Diagnosed at Diagnostic & Research Laboratory, Hyderabad

Liaquat Medical Research Journal, 2020
Pure red-cell aplasia (PRCA) or erythroblastopenia is a rare type of anemia or disorder that can be either idiopathic or associated with certain autoimmune diseases and affect red blood cell (RBC) precursors1,2. The disease is often present at birth, and
Faheem Ahmed Memon
doaj  

RIFAMPICIN INDUCED PURE RED CELL APLASIA

Zdravniški Vestnik, 2008
BACKGROUND Pure red cell aplasia (PRCA) is a rare condition of severe anemia characterized by anabsence of erythroid precursor in the bone marrow, severe reticulocytopenia and normalplatelet and leukocyte count.
Marija Čeh
doaj  

Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab

Haematologica, 2010
Background Pure red cell aplasia and moderate aplastic anemia are marrow failure states with an immune pathogenesis. Previously, we described short-term improvements in blood counts in two pilot studies treating moderate aplastic anemia (mAA) and pure ...
Elaine M. Sloand, Matthew J. Olnes, Barbara Weinstein, Colin Wu, Jaroslaw Maciejewski, Phillip Scheinberg, Neal S. Young   +6 more
doaj   +1 more source

Pure Red Cell Aplasia Associated With Thymoma

Cureus, 2023
A 27-year-old male with thymoma presented with recurrent severe anemia which required multiple transfusions. Bone marrow biopsy showed pure red cell aplasia with normal other cell lineages. He was diagnosed with pure red cell aplasia associated with thymoma and treatment with cyclosporine A was begun.
openaire   +2 more sources

Somatic Mutations in Acquired Pure Red Cell Aplasia: Incidence and Implications

American Journal of Hematology, Volume 101, Issue 7, Page 1554-1555, July 2026.
Robert T. Means Jr
wiley   +1 more source

Donor‐Related Factors Affecting Haploidentical HSCT Outcomes in Acute Leukemia: A Single‐Center Retrospective Cohort Study of a Modified Combination of Anti‐Thymocyte Globulin and Post‐Transplant Cyclophosphamide

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Haploidentical hematopoietic stem cell transplantation (haplo‐HSCT) provides curative therapy for patients lacking HLA‐matched donors, yet optimal donor characteristics remain uncertain. This study assessed the effect of donor relationship, age, sex, and ABO compatibility on outcomes of haplo‐HSCT for acute leukemia under a
Mahtab Mashayekhi, Sahar Saeidi, Ghazaleh Kheiri, Fatemeh Salemi, Marjan Masoud, Sahar Tavakoli, Hanieh Rouzbahani, Mohammad Vaezi, Mohammadreza Ostadali Dehaghi, Mojtaba Azari, Ghasem Janbabai, Maryam Barkhordar   +11 more
wiley   +1 more source